Company ProfilePremium

Golden Rock Global Plc

Company Profile Analysis

Ticker: GCG.L

ESOMAR 23 Corporate BadgeISO Certifications Badge
Golden Rock Global Plc - Company showcase

Year Founded & Workforce

2016

3 Employees

Golden Rock Global Plc logo

Golden Rock Global Plc Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Golden Rock Global Plc Overview

Golden Rock Global plc is a Jersey-incorporated, London Main Market-listed cash shell formed in 2016 as a fintech-focused special purpose acquisition company. It has no revenue, no employees and no operating assets; its sole economic purpose is to complete a reverse takeover that converts the listed shell into an operating company. Over ten years it has signed heads of terms on three occasions — with Bolt Global (blockchain media/DeFi, 2021–2023), 2Mee (influencer messaging technology, 2023–2024) and SSS Matrix Corp. (2026, since rebranded StarEdge Digital Infrastructure) — the first two of which collapsed. The company's investment case therefore rests entirely on whether its current RTO with StarEdge, a datacenter-focused hardware, energy-efficiency and quantum-security business, completes on acceptable terms. Following a 2025 recapitalisation via convertible loan notes and warrants, the shell held £0.73 million of cash at 30 June 2026, but carries very significant dilution overhang, a qualified audit opinion and documented governance lapses.


Company's own description

In its FY2025 Directors' Report (RNS 14 May 2026), the company describes its principal activity as seeking and completing a reverse takeover in the financial or other technologies sectors. The notes to the same accounts describe the principal activity as seeking acquisition opportunities focused on the financial and technology sector. The company's IPO announcement (31 October 2016) framed it as a SPAC formed to undertake one or more acquisitions of a target company or business in the fintech sector. The H1 2026 interim statements describe the single operating segment as "investing activity".

Independent characterisation

Golden Rock Global is best characterised as a listed corporate vehicle (a "clean shell") whose only asset of strategic value is its Main Market listing. Its business model is not to generate revenue but to:

  1. Maintain the listing and regulatory compliance at minimum cost (audit, registrar, legal, FCA and LSE fees, director fees).

  2. Source and negotiate a private target that wishes to obtain a Main Market listing by reverse takeover rather than by IPO.

  3. Fund the transaction costs (legal, reporting accountant, sponsor) through convertible debt and warrants until completion.

  4. Issue consideration shares to the target's owners on completion, so that existing shell shareholders retain a minority stake in a larger operating company.

The directors explicitly market the company on this basis: in the 28 August 2025 shareholder update they described GCG as among the first companies listed as a clean shell on the Main Market under the revised UK Listing Rules for shell companies, and therefore an attractive partner for companies seeking a Main Market listing via RTO.

Revenue model and mix

Revenue typeShare of revenueComment
Product0%No products
Service0%No services
Subscription0%Not applicable
Licensing0%Not applicable
Other incomeEpisodicFY2022 recognised £172,415 of "other income" representing professional fees reimbursable by Bolt Global under the aborted RTO cost-sharing agreement
Finance incomeNegligible£720 (FY2025); £1,371 (H1 2026) bank/loan interest

Value chain position

The company sits in the capital-markets access segment of the corporate finance value chain — a supplier of listing infrastructure to private companies. Its "customers" are, in effect, prospective RTO targets; its "suppliers" are its professional advisers (sponsor, broker, lawyers, auditors, registrar) and its funders (CLN subscribers).

End-markets

Current (shell): UK listed-shell / RTO market; private companies seeking a London listing.

Prospective (post-RTO, if StarEdge completes): datacenter infrastructure — AI-capable server sourcing, sales, leasing and installation; datacenter energy-optimisation hardware/software; quantum-security procurement; quantum chip sales (per the 23 July 2026 Proposed Acquisition Update). The earlier January 2026 description of SSS Matrix additionally referenced applied AI, commodity markets and supply chain management, and blockchain-based digital finance and payments; the July 2026 restructuring narrowed this to datacenter infrastructure.

Strategy

Stated strategy (themes from FY2025 Annual Report and 2026 announcements)

Primary objective: complete the current reverse takeover transaction (StarEdge) during 2026 and create enhanced value for shareholders (Chairman's statement, 13 May 2026).

Pipeline: the Board states it maintains access to a strong pipeline of targets with strong management teams and good growth prospects, should the current transaction fail.

Positioning: market the company as a "clean shell" under the revised UK Listing Rules shell companies regime, offering a faster route to a Main Market listing than an IPO (Shareholder update, 28 August 2025).

Sector focus: originally fintech (2016 IPO); now "financial or other technologies" — in practice broadened to datacenter infrastructure.

Investment process: third-party legal, commercial and financial due diligence, site visits, management meetings and independent valuations where relevant (QCA statement, FY2025).

Strategic initiatives (last 24 months)

InitiativeDateDetailStatus
Recapitalisation / refinancingApr–Jul 2025NE10 Vodka CLN (£300k, later £500k facility; £180k drawn)Superseded; NE10 refinanced Feb 2026 and repaid Jun 2026
Listing restorationAug 2025Restored under shell companies categoryAchieved 21 Aug 2025; re-suspended Jan 2026
October 2025 CLN programmeOct 2025 – Jun 2026Up to £1.0m, increased to £1.5m; £1.49m raised; 8% coupon; 3p fixed conversion; 1-for-2 warrants at 3pFully drawn
StarEdge RTOJan 2026 – presentNon-binding exclusive heads of terms; share-for-share consideration; target restructured and rebranded July 2026In due diligence; sponsor (SPARK) appointed; no SPA signed as at 30 Sep 2026
Simplified prospectus for CLN conversion sharesAnnounced 23 Jun 2026Targeted publication by end-July 2026No publication identified in RNS feed through 30 Sep 2026 — appears delayed
Cost programme—No formal cost programme; costs described as kept to a minimum—
ESG / sustainability commitments———

Medium-term financial targets / guidance

None. The company has issued no financial guidance, no medium-term targets, and no investor day. The only forward-looking commitment is the aspiration to complete the RTO in 2026.

Products & Services

Golden Rock Global plc

The company has no products, brands, platforms or services. Not applicable.

Proposed RTO target — StarEdge Digital Infrastructure Inc. (formerly SSS Matrix Corp.)

Offering (as described by GCG)DescriptionTarget customerLaunch / versionPricing modelNamed flagship
Datacenter hardware & software procurementSourcing of hardware/software to improve quantum security, energy usage and computing powerTraditional and new datacenters———
Server sales, leasing & installationAI-capable server supply, leasing and installationDatacenters—Sale and lease (terms not disclosed)—
Servicing & maintenanceMaintenance of installed hardwareDatacenters—Presumably recurring service contracts — not disclosed—
Quantum chip salesSale of quantum chips————
Legacy (pre-restructuring, Jan 2026 description)Applied AI, commodity trading and supply-chain/logistics management, blockchain-based digital finance and payments, tokenisation contracts—Expanded in H2 2025 per GCG——

The following is drawn solely from the company's 22 January 2026 and 23 July 2026 announcements. No specifications, pricing, launch dates or named flagship products have been publicly disclosed.

Analyst observation. The scope narrowed markedly between January 2026 (a multi-vertical AI/commodities/blockchain group) and July 2026 (a datacenter infrastructure business). Whether legacy commodity-trading, logistics and tokenisation activities were divested, retained outside the perimeter, or reclassified is not disclosed. Investors should require the prospectus to reconcile the two descriptions.

Historical (aborted) targets — for context

TargetPeriodOffering
Bolt Global LimitedNov 2021 – Apr 2023Blockchain-based media and decentralised finance ecosystem
2Mee LimitedAug 2023 – Aug 2024Patented omnichannel communication platform delivering influencers as on-screen web and app messages; product lines HoloAd® and HoloMessage®

Financial Narrative

Sources: FY2021 and FY2022 — FY2022 Annual Report (RNS 28 April 2023); FY2024 and FY2025 — FY2025 Annual Results (RNS 14 May 2026); FY2023 — derived from opening balances in the FY2025 Annual Report statement of changes in equity and cash flow statement (the FY2023 accounts themselves, published 22 July 2025, were not available in full in the sources reviewed). H1 figures from interim statements. Blank cells = not obtained / not publicly disclosed in sources reviewed.

Income statement

Notes: (a) FY2021 directorship fees are a net credit of £80,958 because three directors waived accumulated accrued remuneration of £127,500 (FY2022 Annual Report, note 7). (b) EBITDA equals operating loss — the company has no depreciation or amortisation. (c) FY2025 directorship fees of £97,378 include a £51,128 share-based charge for director warrants; cash fees were £46,250 (£17,500 Paul Carroll; £28,750 John Croft). (d) The FY2025 income statement prints the net loss as £865,397 in one line and £865,367 elsewhere; £865,367 is used here. (e) Loss per share figures are reported as negative values (losses); shown here as positive magnitudes.

Half-year comparison

Source: H1 2026 Interim Statements (RNS 30 Sep 2026). Note the H1 2026 chairman's statement describes the H1 2026 figure of £656,355 as the "operating loss"; the income statement shows operating loss of £629,037 and loss before tax of £656,355.

Margins and growth

All margin metrics are not meaningful (zero revenue). Revenue CAGR FY2021–FY2025: not meaningful (zero base and zero end).

Balance sheet

Notes: (a) Working capital equals total equity because all assets and liabilities are current. (b) CLN principal largely sits within equity (as "prepaid equity" and "equity options") under management's IAS 32 classification, which the auditor disputes (see 6.8). On the auditor's view, the £585,000 of CLNs outstanding at 31 Dec 2025 would be classified as financial liabilities, which would make FY2025 equity substantially negative and net debt positive. (c) FY2023 equity: the statement of changes in equity shows −£70,162, while the components sum to approximately −£69,442 — a minor internal inconsistency in the company's figures.

30 June 2026 balance sheet (H1 2026 Interims): cash £728,659; loan receivable (to chairman) £80,587; other receivables £11,116; total assets £820,362; trade creditors £164,291; accruals £32,685; financial liability nil; total liabilities £196,976; equity £623,386 (including prepaid equity £1,163,957 and equity options £471,023); accumulated losses £3,742,339.

Cash flow

FY2023 CLN figure reflects the £100,000 Wei Chen CLN drawn 10 January 2023 (FY2022 Annual Report, note 17); FY2023 net change in cash derived from closing cash £34,335 (FY2022) to £9,797 (FY2023). The July 2023 placing of 3,800,000 shares at 2.5p (gross £95,000) also fell in FY2023; operating cash flow for FY2023 was not obtained.

H1 2026 cash flow (Interims): operating cash outflow £369,892; loan advance to director £80,000; repayment to NE10 £130,000 (per cash flow; the related-party note separately records a £145,000 payment on 30 June 2026 creating a £4,606 overpayment receivable); CLN prepayments received £1,035,000; share issue £659; net cash increase £455,767.

Ratios

ROE, ROIC, debt/equity, net debt/EBITDA, interest coverage and cash conversion cycle are not meaningful (negative or near-zero equity in several years, negative EBITDA, no revenue, no inventory or receivables cycle). ROA computed on average total assets: FY2022 £165,906 / £164,865; FY2025 £865,367 / £144,196.

Commentary on trends, inflections and drivers

Cost base. In "dormant" years the shell's cash running cost is modest — roughly £100,000–£150,000 per year (FY2021 underlying, FY2024). Costs spike whenever a transaction is live: FY2022 professional fees of £257,892 reflected the Bolt RTO (partly offset by £172,415 reimbursable by Bolt), and H1 2026 professional fees of £316,449 reflect StarEdge transaction work. The FY2025 headline loss of £865,367 is inflated by £529,322 of non-cash warrant charges; the cash-adjusted loss was £315,816.

Inflection in 2025. FY2024 was the trough: cash of just £1,867 against £217,857 of liabilities, negative equity of £209,574, and a suspension caused by the inability to pay for an audit. The 2025 recapitalisation (NE10 CLN, October CLN, broker warrant exercise) lifted cash to £272,892 by year-end and to £728,659 by 30 June 2026, while creditor settlements at a discount reduced trade creditors from £87,277 to £13,105.

Cost of the recapitalisation. The recovery was purchased with heavy dilution instruments: 22,750,000 warrants struck at £0.00021978 (essentially nil-cost), 3,340,000 director warrants at 0.3p, CLN-linked warrants at 3p, and £1.49m of CLNs convertible at 3p. Accumulated losses rose from £2.22m to £3.74m in eighteen months.

Cash runway. H1 2026 operating cash burn of £369,892 implies roughly £60,000–£65,000 per month while the RTO is live. Against £728,659 of cash at 30 June 2026 (plus the £80,587 director loan due back 18 October 2026), the runway on that run-rate is about 11–13 months from 30 June 2026 — but RTO completion costs (sponsor, reporting accountant, prospectus) and abort costs could compress this materially. The CLN facility is fully drawn.

Audit quality flags

FY2025 — qualified opinion: (PKF Littlejohn, 13 May 2026): the auditor disagreed with management's IAS 32 classification of the June and October 2025 CLNs (total £585,000 due at year-end, of which £122,452 was allocated to equity as an embedded derivative), stating the derivative and host contract should be financial liabilities.

  • FY2025 — material uncertainty on going concern, with the forecast materially reliant on the £1m Shin Nieh Group CLN subscription executed 24 April 2026.

FY2022 — material uncertainty on going concern: (unmodified opinion).

Late filings: FY2023 audit could not be completed on time (suspension August 2024); FY2023 and FY2024 accounts were only published on 22 July 2025; FY2025 accounts missed the 30 April 2026 deadline and were published 14 May 2026.

Internal controls: the FY2025 report states the Board considers internal controls "no more than adequate" and that a more comprehensive system needs implementing immediately.

Interim document errors: the H1 2026 chairman's statement gives the 30 June 2025 cash comparative as £272,892 (which is actually the 31 December 2025 figure; the H1 2025 figure was £85,500).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityJurisdictionOwnershipFunctionStatus

Golden Rock Global plc

Jersey (no. 121560)

Listed parent

Listed cash shell

Active; shares suspended

Golden Rock Services Limited

England & Wales (no. 13036001)

100%

Held cash and operated UK banking until 31 March 2025

Dormant since 31 March 2025

Revenue by Segment (GBP)

SegmentFY2023FY2024FY2025

Cash shell (single segment) revenue (GBP)

000

Cash shell operating loss (GBP)

—127,919845,858

Cash shell loss before tax (GBP)

287,334131,816865,367

Income Statement (GBP) and Share Count (millions)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (GBP)

00000

Gross profit (GBP)

00000

Professional fees (GBP)

149,304257,892—97,902202,883

Directorship fees net (GBP)

-80,95855,000—26,90097,378

Other expenses (GBP)

24,91025,429—3,11767,403

Share-based payments (GBP)

00—0478,194

Total operating costs (GBP)

93,256338,321—127,919845,858

Other income (GBP)

0172,415—00

Operating loss (GBP)

93,256165,906—127,919845,858

EBITDA loss (GBP)

93,256165,906—127,919845,858

Finance income (GBP)

00—0720

Finance costs (GBP)

00—3,89720,229

Loss before tax (GBP)

93,256165,906287,334131,816865,367

Tax (GBP)

00000

Net loss (GBP)

93,256165,906287,334131,816865,367

Basic & diluted loss per share (pence)

0.490.87—0.573.34

Weighted average shares (millions)

19.17519.175—22.97525.884

Dividends per share (pence)

00000

Key Financials (GBP)

MetricH1 2025H1 2026

Professional fees (GBP)

95,708316,449

Directorship fees (GBP)

16,25040,000

Other expenses (GBP)

108100,687

Share-based payments (GBP)

0171,901

Operating loss (GBP)

112,066629,037

Fair value loss through P&L (GBP)

174,9356,471

Finance costs (GBP)

1,71222,218

Loss before tax (GBP)

288,713656,355

Loss per share (pence)

1.262.54

Cash-adjusted loss (GBP)

112,066466,160

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025

Net loss YoY change (%)

7873-54556

Balance Sheet (GBP) and Share Count (millions)

MetricFY2021FY2022FY2023FY2024FY2025

Cash and equivalents (GBP)

182,97434,3359,7971,867272,892

Other receivables (GBP)

5,336107,085—6,4167,217

Total assets (GBP)

188,310141,420—8,283280,109

Trade creditors (GBP)

2,613101,102—87,27713,105

Accruals (GBP)

23,00043,527—126,00383,117

Financial liability – CLN (GBP)

00—4,577111,706

Total liabilities (GBP)

25,613144,629—217,857207,928

Short-term debt (GBP)

00—4,577111,706

Long-term debt (GBP)

00000

Net debt (cash) (GBP)

-182,974-34,335—2,710-161,186

Total equity (GBP)

162,697-3,209-70,162-209,57472,181

Accumulated losses (GBP)

1,634,8411,800,7472,088,0812,220,6173,085,984

Goodwill & intangibles (GBP)

00000

Working capital (GBP)

162,697-3,209—-209,57472,181

Shares in issue (millions)

19.17519.17522.97522.97531.325

Cash Flow (GBP)

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (GBP)

-43,929-148,639—-7,930-409,975

Capex (GBP)

00000

Free cash flow (GBP)

-43,929-148,639—-7,930-409,975

Equity issued (GBP)

198,4380—096,000

CLN / prepaid equity raised net (GBP)

00100,0000585,000

Dividends paid (GBP)

00000

Buybacks (GBP)

00000

Net change in cash (GBP)

154,509-148,639-24,538-7,930271,025

Financial Ratios (x) and Returns & Leverage Ratios (%)

RatioFY2021FY2022FY2023FY2024FY2025

Current ratio (x)

7.350.98—0.041.35

Cash / current liabilities (x)

7.140.24—0.011.31

ROA (%)

—-101——-600

Asset turnover (x)

00000

Geographic Revenue

RegionFY2023FY2024FY2025

United Kingdom revenue (GBP)

000

Jersey revenue (GBP)

000

Rest of world revenue (GBP)

000

Total revenue (GBP)

000

Data Point Details

Data pointValueSource / date

Implied IPO price

Approximately 10p (derived: share capital £160,000 + share premium £1,439,100 for 16,000,000 shares at 1 Jan 2021)

FY2022 AR statement of changes in equity

June 2023 price

3.23p (up 13% on the day; traded as high as 4.00p that month)

Alliance News, 28 Jun 2023

July 2023 placing price

2.5p

FY2025 AR note 15

April 2025 market cap

£700.7k (implies ~3.05p on 22.975m shares)

TipRanks, Apr 2025

September 2025 market cap

£605.6k

TipRanks, Sep 2025

Share price used in Oct 2025 CLN warrant valuation

3.30p

FY2025 AR note 17

Last traded price (pre-suspension)

3.45p

Morningstar UK, May 2026; H1 2026 note 10 valuation input

Current market cap (stale)

~£1.18m (3.45p × 34.25m)

Calculated

Operating Metrics (millions)

MetricFY2021FY2022FY2023FY2024FY2025

Shares in issue year-end (millions)

19.17519.17522.97522.97531.325

Warrants outstanding year-end (millions)

4.0554.0555.45.435.273

Dividends per share (pence)

00000

Components

ComponentShares (m)Basis

Ordinary shares in issue

34.25

H1 2026 note 8

Warrants outstanding

49.52

H1 2026 note 10

CLN principal conversion at 3p

49.67

£1,490,000 ÷ £0.03

CLN accrued interest conversion (8% p.a., to maturity)

Up to ~11.9

Analyst estimate: 3 years × 8% × £1.49m ÷ £0.03; coupon converts at maturity

Indicative fully diluted total

~145

Before RTO consideration shares and any RTO fundraising

Valuation Multiples

MultipleGCGComment

P/E

n/m

Loss-making

EV/EBITDA

n/m

Negative EBITDA

EV/Sales

n/m

Zero revenue

P/B

~1.9x

£1.18m market cap ÷ £623,386 book equity (30 Jun 2026); equity includes CLN-related reserves disputed by auditor

Market cap / cash

~1.6x

£1.18m ÷ £0.73m cash; implies ~£0.45m premium for the listing and option on RTO

Analyst Conclusions

Management guidance

No financial guidance. Management's stated aim is to complete the StarEdge RTO in 2026 (FY2025 Chairman's statement); the H1 2026 statement (29 Sep 2026) acknowledges unexpected delays due to StarEdge's reorganisation and promises further updates in due course.

Consensus growth expectations

None — no analyst coverage.

Bull case

  1. Transaction is funded and staffed. Unlike 2024, the company has cash (£728,659 at 30 June 2026), a fully subscribed CLN programme (£1.49m) and an appointed sponsor (SPARK), removing the funding failure mode that killed the 2Mee deal.

  2. Thematic tailwind. StarEdge targets AI-datacenter server supply, energy optimisation and quantum security — areas of strong investor interest that could support the required contemporaneous fundraising.

  3. Low entry valuation for the option. At ~£1.2m market cap (~1.6x cash), shell holders hold a cheap option on an RTO that, if StarEdge has genuine revenue, could re-rate the enlarged entity well above the shell value.

Bear case

  1. Track record. Two prior RTOs collapsed (2023, 2024) after prolonged suspensions; the current deal is still non-binding nine months after announcement and the target has already restructured.

  2. Dilution and capital structure. ~145m fully diluted shares pre-RTO (vs 34m in issue), including 22.75m warrants issued at ~0.02p, mean existing holders' economic interest is thin; a Rule 9 whitewash implies vendors will take control.

  3. Governance and reporting quality. Qualified FY2025 audit, repeated late filings, internal inconsistencies across documents (share count, cash comparative, net loss), and an undisclosed related-party loan to the chairman undermine confidence in the information that will underpin the prospectus.

Catalysts and monitorables (next 12 months)

CatalystExpected timingWhy it matters
Repayment of £80k loan to chairmanDue 18 October 2026Test of governance; non-repayment would be a red flag
Signing of definitive SPA with StarEdgeNot guidedConverts non-binding HoT into binding deal; triggers UKLR 13.4.22R disclosure
Publication of simplified prospectus for CLN conversion sharesWas targeted end-July 2026Overdue; signals FCA engagement
Disclosure of StarEdge audited financialsWith prospectusFirst view of target revenue, profitability, jurisdiction, ownership
Identity of Shin Nieh Group and any links to StarEdgeProspectus / RNSConcert-party and Rule 9 implications
RTO fundraising size and priceAt readmissionDetermines final dilution and enlarged-group valuation
Rule 9 waiver voteGeneral meeting pre-completionIndependent shareholder approval
Cash burn vs £0.73m (June 2026)OngoingRisk of further CLN/warrant issuance if delays persist
FY2026 audit opinionBy 30 April 2027Whether qualification on CLN classification recurs
Lapse/restoration of suspensionEvent-drivenIf StarEdge fails, company must apply for restoration

Concluding analyst verdict

Golden Rock Global plc is not an operating company and cannot be valued on any conventional metric: it has generated no revenue in ten years of listed existence, has no employees, and its only assets are roughly £0.8m of current assets and a Main Market shell listing.

The 2025–2026 recapitalisation was genuinely consequential. It rescued a shell that, at end-2024, had under £2,000 of cash and could not afford its own audit, and it has funded a credible advisory team for the current transaction. That is the principal difference between this attempt and the failed 2Mee deal. However, the price of that rescue has been a capital structure in which existing ordinary shares represent only about a quarter of the pre-RTO fully diluted count, with a large tranche of warrants exercisable at effectively nil cost. Any RTO will also hand control to the vendors.

Governance is the dominant concern. A qualified audit, three late annual reports in three years, internally inconsistent figures, and an undisclosed material loan to the chairman — himself a director of a former lender — fall well short of the standard investors should expect from the vehicle through which a new business will be presented to the market. The shift in the target's described business between January and July 2026 heightens the need for rigorous prospectus disclosure.

Verdict: highly speculative. The near-term decision points are repayment of the chairman's loan (due 18 October 2026), signature of a binding SPA, and the first disclosure of StarEdge's audited financials. Absent those, the probability-weighted value of the shell should be anchored to its net cash, discounted for ongoing burn and abort costs.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleAppointedTenureBackground (per company disclosures)

Paul Carroll

Non-Executive Chairman

30 May / 4 Jun 2025 (both dates appear in FY2025 report)

~1.3 years

Entrepreneur and C-suite executive; founded and developed businesses in manufacturing, technology and digital sectors in the UK, USA and Canada; specialises in sustainable business modelling, growth capital financing and M&A; director of NE10 Vodka Ltd

John Croft

Independent Non-Executive Director (company contact)

2016

~10 years

Board director focused on governance; served on boards and committees of international companies in financial services, resources and TMT, including LSE-listed companies based in Malaysia, Hong Kong, China and Australia; based in Dubai; principal of Croft International Partners (per email domain)

Directors' Remuneration

DirectorCash fees FY2025 (GBP)Share-based FY2025 (GBP)Total FY2025 (GBP)Total FY2024 (GBP)

Paul Carroll

17,50025,56443,0640

John Croft

28,75025,56454,31425,000

Ross Andrews

0001,900

Wei Chen

0000

Total

46,25051,12897,37826,900

Directors' Shareholdings

DirectorOrdinary shares%Warrants

Paul Carroll

001,670,000

John Croft

00

2,070,000 (400,000 at 2.5p expiring 20 Jul 2026, plus 1,670,000 at 0.3p)

Ross Andrews (resigned)

00400,000

Board & Management Changes

DateChangeContext

1 Apr 2025

Ross Andrews resigns as Chairman

Followed collapse of 2Mee deal and FY2023 audit funding crisis

3 Apr 2025

Paul Carroll announced to join board

Linked to NE10 Vodka refinancing

30 May 2025

Wei Chen (founder, executive director) resigns

Coincides with capital reorganisation; Chen family no longer among disclosed substantial holders by Jan 2026

May/Jun 2025

Paul Carroll appointed; becomes Chairman

—

Major Shareholders

HolderShares%

Leon Hogan

5,400,00015.72

GBS Banking Group

4,480,00013.04

Green Coast Capital LLC

4,390,00012.78

James Brearley & Sons

3,800,00011.06

John Nemanic

3,680,00010.71

Tiger Trout Capital LLC

3,675,00010.70

Disclosed total

25,425,00074.01

Competitive Landscape

Key Competitors

Competitor categoryDescriptionRelative positioning vs GCG

Other LSE Main Market shell companies (Equity Shares – Shell Companies category)

Listed cash shells pursuing RTOs

GCG claims "first mover" status under the revised regime; however, its ten-year record of two failed RTOs and repeated suspensions is a reputational weakness

AIM-quoted cash shells / investing companies

Shells on AIM, subject to AIM rules on time limits for completing acquisitions

AIM shells face nominated adviser oversight and time-bound deployment; Main Market listing may appeal to targets wanting higher-profile status

Aquis Stock Exchange (AQSE) shells

Lower-cost growth market shells

Cheaper, less prestigious; competes for smaller targets

Direct IPO on LSE Main Market / AIM

Traditional IPO with bookbuild

Provides cleaner capital structure; RTO via GCG offers speed but carries GCG's dilution overhang

US SPACs / de-SPAC transactions

Larger US blank-cheque vehicles with trust cash

Far greater cash in trust; GCG has no trust account

Overseas exchanges (e.g., Nasdaq, NYSE American, HKEX GEM, ASX)

Alternative listing venues

Relevant to a StarEdge-type target with international operations

Competitors by Segment

SegmentNamed competitorsComment

AI-capable servers (sales/leasing/installation)

Super Micro Computer, Dell Technologies, Hewlett Packard Enterprise, Lenovo

Global OEMs with direct supply relationships to GPU vendors; a small reseller/lessor competes on sourcing access, financing and service

Datacenter power and energy optimisation

Schneider Electric, Vertiv, Eaton

Dominant in power, cooling and energy management

Quantum security / post-quantum cryptography

IBM, PQShield

Large-vendor and specialist PQC providers

Quantum hardware / chips

IBM Quantum, IonQ, Quantinuum, Rigetti Computing

Capital-intensive; StarEdge's role (manufacturer vs reseller) is not disclosed

Datacenter maintenance / services

OEM service arms; independent third-party maintenance providers

Fragmented

Peer Comparison FY2025

CompanyFY2025 revenueR&D intensity

Golden Rock Global plc

£0

0%

Super Micro Computer

Approx.

—

Dell Technologies

Approx.

—

Vertiv

Approx.

—

Recent Developments

No contract wins, product launches, layoffs or litigation (the company has no operations).

Company Snapshot

3

Employees

2016

Founded

St Helier, Jersey

Headquarters

SWOT Analysis

Strengths

  • Main Market listing in good standing as a shell category issuer — restored 21 August 2025 under the revised rules (RNS 21 & 28 Aug 2025).
  • Cash materially rebuilt — £728,659 at 30 June 2026 versus £1,867 at 31 December 2024 (H1 2026 Interims; FY2025 AR).
  • Funding programme completed — £1,490,000 CLN fully subscribed by 23 June 2026 (RNS 23 Jun 2026).
  • Professional transaction team in place — SPARK Advisory Partners appointed as financial adviser and sponsor; legal and reporting accountants appointed (H1 2026 Interims).
  • Low dormant-state cost base — FY2024 operating loss only £127,919 and operating cash outflow only £7,930 (FY2025 AR comparatives).
  • Zero tax leakage and no debt maturities — Jersey 0% tax rate; no long-term debt; NE10 loan settled 30 June 2026 (FY2025 AR note 10; H1 2026 note 12).

Weaknesses

  • No revenue in any year since 2016 — FY2021–FY2025 revenue £0 (all annual reports).
  • Qualified audit opinion on FY2025 over CLN classification (PKF Littlejohn, 13 May 2026).
  • Track record of failed RTOs — Bolt (terminated 5 Apr 2023) and 2Mee (terminated 27 Aug 2024).
  • Governance capacity — two-director board, no executives, committee functions performed by full board; no committee meetings in FY2025 (FY2025 AR).
  • Disclosure and filing lapses — late FY2023, FY2024 and FY2025 accounts; undisclosed £80k loan to chairman in breach of DTR 7.3 (RNS 30 Apr 2026; H1 2026 note 12).
  • Accumulated losses of £3.74m against total historical equity raised of roughly £2.0m in share capital and premium (H1 2026 balance sheet).

Opportunities

  • StarEdge RTO could transform GCG into an operating company in a high-demand AI-infrastructure niche (RNS 23 Jul 2026).
  • Vendor-share consideration means no cash outlay for the acquisition (RNS 22 Jan 2026).
  • Contemporaneous fundraising at RTO could recapitalise the enlarged group (completion condition, RNS 22 Jan 2026).
  • Board strengthening — consideration shares holders/management are expected to join the board (RNS 22 Jan 2026).
  • Fallback pipeline — Board asserts access to a strong pipeline of alternative targets (FY2025 AR QCA statement).
  • Conversion of CLNs to equity would eliminate the residual liability classification issue raised by the auditor (FY2025 AR note 16).

Threats

  • RTO failure — conditions include due diligence, SPA, FCA prospectus approval, fundraising and Rule 9 waiver (RNS 22 Jan 2026); two prior deals failed at similar stages.
  • Timetable slippage — simplified prospectus targeted for end-July 2026 not evidenced by 30 Sep 2026; delays attributed to target reorganisation (H1 2026 Interims).
  • Prolonged suspension — shares suspended since 21 January 2026, removing liquidity for holders.
  • Liquidity squeeze — H1 2026 cash burn £369,892; CLN facility fully drawn; abort costs could exhaust cash (H1 2026 Interims).
  • Severe dilution — 49.5m warrants plus ~50m CLN conversion shares against 34.25m shares in issue, before any RTO consideration shares (H1 2026 notes 9–10).
  • Target opacity and scope change — SSSM's January description (AI, commodities, blockchain payments, tokenisation) materially differs from StarEdge's July description (datacenter infrastructure); no target financials disclosed.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025Board changes — Ross Andrews resignsEnd of the original independent chairmanship
3 Apr 2025£300k NE10 Vodka refinancing; Paul Carroll to join boardLifeline enabling audits and listing restoration
2 May 2025Auditor appointmentPrerequisite for delinquent FY2023/FY2024 audits
30 May 2025Wei Chen resigns; 4.55m shares issued at sub-par price; 22.75m near-nil-cost warrants issued for fundraising and target assistanceFounder exit; major dilution instrument
4 Jun 2025Capital reorganisation; NE10 CLN instrument (£300k) executedCapital structure reset
20 Jun 2025Registered office moves to 36 Hilgrove StreetAdministrative
23 Jun 2025Convertible loan — £180k drawn from NE10Creditor settlements funded at a discount
22 Jul 2025FY2023 and FY2024 annual reports published; NE10 facility increased to £500k; director warrants (3.34m at 0.3p)Compliance restored; insider incentive
19 Aug 2025Notice of AGMGovernance
21 Aug 2025Restoration of listingShares tradeable for first time since Aug 2024
28 Aug 2025Shareholder update — company markets itself as one of the first clean shells under revised rulesPositioning for RTO targets
3 Sep 2025H1 2025 interims: loss £288,713; cash £85,500Confirms precarious liquidity pre-CLN
11 Sep 2025Admission of subscription sharesCapital structure
22 Sep 2025Notice of AGM (re-issued)Governance
2–13 Oct 2025Multiple major-holding notifications (TR-1s)Register churn following restoration
7 Oct 2025Advisor appointment (non-regulatory; adviser not identified in sources reviewed)Transaction preparation
17 Oct 2025AGM resultsShare authorities obtained
Oct 2025October CLN — £455k raised at 3p conversion with 1-for-2 warrantsPrimary working capital source
12 Nov 2025Convertible note to raise up to £1.1 million announcedScaling CLN programme
9–10 Dec 20253.8m broker warrants exercised (£95k); £50k repaid to NE10 after NE10 sought repaymentNE10 unable to fund further; relationship unwinds
19–20 Jan 2026Admission of broker shares; TR-1 notificationsCapital structure
21 Jan 20263m warrants exercised for £659; allotment of sharesNear-nil-cost dilution
22 Jan 2026Heads of terms with SSS Matrix Corp.; listing suspendedThird RTO attempt begins
4 Feb 2026Admission of 3m shares; issued capital stated as 34,325,000Capital structure (conflicts with interim figure of 34,250,000)
18 Feb 2026Notification of major holdingsRegister
25 Feb 2026Cancellation of NE10 CLN; replaced by £140,394 non-interest-bearing loanRemoves conversion overhang from related party
17 Mar 2026CLN fundraising update — instrument raised to £1.5m; 17.25m additional warrantsRTO funding
24 Apr 2026CLN subscriptions: Shin Nieh Group £1m; B Liceaga £35kGoing concern hinges on this
30 Apr 2026Delay in publishing FY2025 annual reportListing Rules deadline breach
14 May 2026FY2025 results: loss £865,367; qualified audit opinion; going concern uncertaintyAccounting and solvency red flags
28 May 2026£80k loan to chairman (undisclosed until Sep 2026)Governance lapse (DTR 7.3)
23 Jun 2026CLN fundraising complete at £1.49m; early due diligence on SSSM described as positive; simplified prospectus targeted for end-JulyFunding complete; timetable set
30 Jun 2026£145k paid to NE10 in settlement (overpaid by £4,606)Related-party unwinding
23 Jul 2026SSSM restructured and rebranded StarEdge Digital Infrastructure Inc.; sponsor appointment expectedTarget scope narrowed to datacenter infrastructure
30 Sep 2026H1 2026 interims: loss £656,355; cash £728,659; SPARK named sponsor; DTR 7.3 lapse disclosed; delays attributed to target reorganisationLatest status; RTO still pre-SPA

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

1 chart
Revenue by Segment (GBP): Cash shell operating loss rose from GBP 127,919 in FY2024 to GBP 845,858 in FY2025.
Golden Rock Global Plc — Revenue by Segment (GBP)
Series (GBP)FY2023FY2024FY2025
Cash shell operating loss—127,919845,858
Cash shell loss before tax287,334131,816865,367

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. 1Admission to Trading (IPO), RNS 8046N — 31 Oct 2016 (investegate.co.uk)
  2. 2Interims for period ended 30 June 2019 — 23 Sep 2019 (investegate.co.uk)
  3. 3Result of AGM — 20 Jul 2021 (sharesmagazine.co.uk)
  4. 4Half-year report H1 2022 — 18 Oct 2022 (sharesmagazine.co.uk)
  5. 5FY2022 Annual Financial Report — 28 Apr 2023 (investegate.co.uk)
  6. 6Termination of discussions with Bolt; Restoration of trading — 5 Apr 2023 (sharesmagazine.co.uk)
  7. 7Alliance News — shares rise, talks over acquisitions — 28 Jun 2023 (streaming1.beta.ajbell.co.uk)
  8. 8Proposed Transaction (2Mee) and Suspension — 17 Aug 2023 (investegate.co.uk)
  9. 9H1 2023 Half-year report — 29 Sep 2023 (ticker.app)
  10. 10Termination of discussions (2Mee) and Suspension — 27 Aug 2024 (ticker.app)
  11. 11Refinancing (NE10 Vodka) — 3 Apr 2025 (sharesmagazine.co.uk)
  12. 12Annual Financial Report / Corporate update (FY2023–FY2024 accounts) — 22 Jul 2025 (investegate.co.uk)
  13. 13Shareholder Update (trading resumption) — 28 Aug 2025 (ticker.app)
  14. 14H1 2025 Interim Financial Statements — 3 Sep 2025 (ticker.app)
  15. 15Admission of Broker Shares — 20 Jan 2026 (ticker.app)
  16. 16Proposed Acquisition (SSS Matrix), Suspension of Trading — 22 Jan 2026 (investegate.co.uk)
  17. 17Admission of Shares — 4 Feb 2026 (ticker.app)
  18. 18Delay in Publishing 2025 Annual Financial Report — 30 Apr 2026 (www-proxy.stockopedia.com)
  19. 19FY2025 Annual Results (full text) — 14 May 2026 (www-proxy.stockopedia.com)
  20. 20Alliance News — annual loss widens amid RTO plans — 14 May 2026 (ajbell.co.uk)
  21. 21Morningstar UK (Alliance News, price 3.45p) — 14 May 2026 (morningstar.co.uk)
  22. 22CLN Fundraising and Acquisition Update — 23 Jun 2026 (investegate.co.uk)
  23. 23Independent commentary — FY2025 qualified opinion — 15 Jul 2026 (joshthompson.co.uk)
  24. 24Proposed Acquisition Update (StarEdge rebrand) — 23 Jul 2026 (investegate.co.uk)
  25. 25Unaudited 2026 Interim Financial Statements — 30 Sep 2026 (investegate.co.uk)
  26. 26Investegate RNS index (announcement list, pages 1–2) — Accessed Oct 2026 (investegate.co.uk)
  27. 27TipRanks — refinancing / H1 2025 coverage (market cap data points) — Apr & Sep 2025 (tipranks.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.